The effect of using automated APRI calculation in pathology on diagnosis of liver cirrhosis and linkage to care: The Cirrhosis Automated APRI Screening Evaluation (CAPRISE) Study
Not Applicable
Recruiting
- Conditions
- liver cirrhosisOral and Gastrointestinal - Other diseases of the mouth, teeth, oesophagus, digestive system including liver and colonPublic Health - EpidemiologyPublic Health - Health service research
- Registration Number
- ACTRN12623000295640
- Lead Sponsor
- St Vincent's Hospital Melbourne
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- All
- Target Recruitment
- 100000
Inclusion Criteria
All individuals aged 18 years and over who have liver function tests and full blood count performed at St Vincent’s Pathology between 9 August, 2022-December 31, 2023
Exclusion Criteria
Blood tests performed during a hospital inpatient stay, defined by St Vincent’s Pathology records (blood collection site).
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method